HIV Infection: Immunology and Vaccine Design [ 2004 - 2008 ]

Research Grant

Researchers: Prof Peter Doherty (Principal investigator) ,  Prof David Cooper ,  Prof Ian Ramshaw ,  Prof Stephen Kent

Brief description This program application seeks to draw on the skills of a world leading group of Australian researchers to bring novel HIV vaccine designs to clinical trials, improve vaccine design and create new opportunities for commercialisation. The Chief Investigators, Prof David Cooper, Prof Peter Doherty (Nobel Prize winner), A-Prof Stephen Kent and Prof Ian Ramshaw, have achieved major scientific developments including: innovative collaborative clinical trials, cutting edge research in T cell immunology, the establishment of the only PC3-level nonhuman primate facility in the Southern hemisphere, T cell immunogenicity of the DNA-viral vector prime-boost vaccine regimens and ground-breaking research on cytokine co-expressing viral vector vaccines. The Principle Investigators also have a record of substantial achievement in relation to HIV and T cell biology as well as novel vaccination technologies. There is a strong history of successful collaboration among this group leading to the award of major NIH funding.

Funding Amount $AUD 7,413,040.76

Funding Scheme Programs

Notes Program Grant